Overview New York, NY Nov 27, 2025 Global GLP-1 Receptor Agonist Market size is expected to be worth around US$ 268.4 billion by 2034 from US$ 53.5 billion in 2024, growing at a CAGR of 17.5% during the forecast period 2025 to 2034
For the side effect phenotypes, the effect size represents log-odds ratio, whereas for the efficacy phenotype, the effect size represents percentage BMI change
As shown in the Table above there are three known polymorphisms in the ADH1B gene and two in the ADH1C gene
Focally administered succinate improves cerebral metabolism in traumatic brain injury patients with mitochondrial dysfunction
The material and videos on this website are provided for information purposes only and are not medical advice
Blood-brain barrier passage : One of ALC's most notable advantages is its ability to cross the blood-brain barrier, which L-Carnitine lacks